indole-3-ethyl isothiocyanate

synthetic cpd that enhances sensitivity of human ovarian carcinoma cell lines A2780 and A2780/CP to cisplatin

Also Known As:

homoITC cpd

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Carcinoma (Carcinomatosis) 01/01/2010 - "Synthetic isothiocyanate indole-3-ethyl isothiocyanate (homoITC) enhances sensitivity of human ovarian carcinoma cell lines A2780 and A2780/CP to cisplatin."